Magnetic Resonance - Technology Information Portal Welcome to MRI Technology
Info
  Sheets

Out-
      side
 



 
 'Ultra' 
SEARCH FOR    
 
  2 3 5 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Result : Searchterm 'Ultra' found in 4 terms [] and 80 definitions []
previous     36 - 40 (of 84)     next
Result Pages : [1]  [2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17]
Searchterm 'Ultra' was also found in the following services: 
spacer
News  (116)  Resources  (62)  Forum  (8)  
 
Cardiovascular ImagingMRI Resource Directory:
 - Cardiovascular Imaging -
 
Cardiovascular MR imaging includes the complete anatomical display of the heart with CINE imaging of all phases of the heartbeat. Ultrafast techniques make breath hold three-dimensional coverage of the heart in different cardiac axes feasible. Cardiac MRI provides reliable anatomical and functional assessment of the heart and evaluation of myocardial viability and coronary artery disease by a noninvasive diagnostic imaging technique.
Cardiovascular MRI offers potential advantages over radioisotopic techniques because it provides superior spatial resolution, does not use ionizing radiation, has no imaging orientations constraints and contrast resolution better than echocardiography. It also offers direct visualization and characterization of atherosclerotic plaques and diseased vessel walls and surrounding tissues in cardiovascular research.
MRI perfusion approaches measure the alteration of regional myocardial magnetic properties after the intravenous injection of contrast agents and assess the extent of injury after a myocardial infarction and the presence of myocardial viability with a technique based on late enhancement. Extracellular MRI contrast agents, like Gd-DTPA, accumulate only in irreversibly damaged myocardium after a time period of at least 10 minutes.
This type of patients may also have an implanted cardiac stent, bypass or a cardiac pacemaker and special caution should be observed on the MRI safety and the contraindications. While a number of coronary stents have been tested and reported to be MRI compatible, coronary stents must be assessed on an individual basis, with the medical team weighing the risks and benefits of the MRI procedure.

Cardiac MRI overview:
Myocardial perfusion imaging and viability
Calculation of ventricular volume, myocardial mass and wall thickness
Functional parameters
Description of a stenosis or aneurysma
Anatomical display of the heart, vessels and the surrounding tissue

Cardiovascular MRI has become one of the most effective noninvasive imaging techniques for almost all groups of heart and vascular disease.
 
Images, Movies, Sliders:
 Angulation of Cardiac Planes Cine Images of Septal Infarct  Open this link in a new window
      

Courtesy of  Robert R. Edelman

 Left Circumflex Ischemia First-pass Contrast Enhancement  Open this link in a new window
      

Courtesy of  Robert R. Edelman

 Delayed Myocardial Contrast Enhancement from Infarct  Open this link in a new window
 
spacer

• View the NEWS results for 'Cardiovascular Imaging' (6).Open this link in a new window.
 
Further Reading:
  Basics:
Cardiac MRI - Technical Aspects Primer
Wednesday, 7 August 2002
Coronary Artery Disease: Combined Stress MR Imaging Protocol-One-Stop Evaluation of Myocardial Perfusion and Function1
   by radiology.rsnajnls.org    
A Guide To Cardiac Imaging
   by www.simplyphysics.com    
  News & More:
New Imaging Technique Reveals Different Heart Motions by Age, Gender
Thursday, 10 December 2009   by www.sciencedaily.com    
MRI Resources 
Resources - Sequences - Education pool - Raman Spectroscopy - DICOM - Shielding
 
Clariscan™InfoSheet: - Contrast Agents - 
Intro, Overview, 
Characteristics, 
Types of, 
etc.MRI Resource Directory:
 - Contrast Agents -
 
An iron-based contrast agent with large molecular size, which prevents diffusion into body tissues and will be developed for MR imaging of the liver (taken up by macrophages), tumor microvasculature and microvessel permeability. The blood half live of the particles with 11-20 nm diameter is 3-4 hours.
At this time the development of Clariscan™ is discontinued.

See also NC100150 Injection and Ultrasmall Superparamagnetic Iron Oxide.
Drug Information and Specification
NAME OF COMPOUND
Feruglose, PEG-feron, USPIO, NC100150
DEVELOPER
CENTRAL MOIETY
Fe
CONTRAST EFFECT
T2, Predominantly negative enhancement
R1=20, R2=35, B0=0.5T
PHARMACOKINETIC
Intravascular
CONCENTRATION
29.8 mg Fe/mL
PREPARATION
Suspend in an isotonic glucose solution
INDICATION
Cardiovascular
DEVELOPMENT STAGE
?
DO NOT RELY ON THE INFORMATION PROVIDED HERE, THEY ARE
NOT A SUBSTITUTE FOR THE ACCOMPANYING PACKAGE INSERT!
spacer

• View the DATABASE results for 'Clariscan™' (6).Open this link in a new window

 
Further Reading:
  News & More:
GE Healthcare expands MRI contrast media product range in Europe with launch of macrocyclic agent ClariscanTM
Wednesday, 1 March 2017   by www.businesswire.com    
GE Healthcare announces FDA approval of macrocyclic MRI contrast agent Clariscan
Monday, 4 November 2019   by www.itnonline.com    
MRI Resources 
Mass Spectrometry - Distributors - IR - MRI Physics - Supplies - Hospitals
 
Combidex®InfoSheet: - Contrast Agents - 
Intro, Overview, 
Characteristics, 
Types of, 
etc.MRI Resource Directory:
 - Contrast Agents -
 
Combidex® is the brand name (same as Sinerem®) for an ultrasmall superparamagnetic iron oxide (USPIO) in the development pipeline to detect metastatic disease in lymph nodes. Metastatic lymph nodes show less uptake of this MRI contrast agent, which results in less signal decrease and allows the differentiation of normal lymph nodes from normal-sized, metastatic nodes. Combidex® has also potential to be used as a functional molecular imaging agent.
In March 2005, AMAG Pharmaceuticals Inc received an approvable letter from the U.S. Food and Drug Administration with respect to Combidex subject to certain conditions.
See also Ferumoxtran, Drug Development and Approval Process USA, Molecular Imaging and Classifications, Characteristics, etc.
Drug Information and Specification
NAME OF COMPOUND
Ferumoxtran, USPIO, AMI-227
CENTRAL MOIETY
Fe3+/Fe2+
CONTRAST EFFECT
T1, predominantly T2
r1=25, r2=160, B0=0.47T, r1=23.3, r2=48.9, B0=0.47T
PHARMACOKINETIC
Vascular, lymph v. hepatocyte (AG-USPIO)
DOSAGE
2.6 mg Fe/kg
PREPARATION
Suspend in an isotonic glucose solution
INDICATION
Lymph node, (MR angiography vascular, staging of RES-directed liver diseases)
DO NOT RELY ON THE INFORMATION PROVIDED HERE, THEY ARE
NOT A SUBSTITUTE FOR THE ACCOMPANYING PACKAGE INSERT!
spacer

• View the DATABASE results for 'Combidex®' (6).Open this link in a new window


• View the NEWS results for 'Combidex®' (1).Open this link in a new window.
 
Further Reading:
  Basics:
The demise of Combidex - Sinerem
Wednesday, 24 March 2010   by www.wellsphere.com    
  News & More:
Combidex, MRI, and identification of nodal metastases
Wednesday, 17 June 2009   by prostatecancerinfolink.net    
Superparamagnetic Iron Oxide–enhanced MR Imaging of Head and Neck Lymph Nodes1
Searchterm 'Ultra' was also found in the following services: 
spacer
News  (116)  Resources  (62)  Forum  (8)  
 
Coronary Angiography with D-TaggingMRI Resource Directory:
 - Cardiovascular Imaging -
 
(MRI-CA) Coronary angiography with dobutamine stress tagging (MR images are taken after the heart has been stressed by using a medication called dobutamine). Investigational noninvasive imaging as a diagnostic tool for evaluating stenosis, anatomy and flow effects in coronary arteries with dobutamine stress.

For Ultrasound Imaging (USI) see Stress Echocardiogram at Medical-Ultrasound-Imaging.com.
spacer

• View the DATABASE results for 'Coronary Angiography with D-Tagging' (3).Open this link in a new window

MRI Resources 
Knee MRI - Mobile MRI - MRI Centers - Pregnancy - Distributors - Case Studies
 
Duty Cycle
 
Duty cycle is the time during which the gradient system can be run at maximum power. The duty cycle is based on the total time and includes the cool down phase. The duty cycle on the RF pulse during MRI is restricted based on the specific absorption rate (SAR) limit.
SAR limits restrict radio frequency heating effects. The specific absorption rate increases with field strength, radio frequency power and duty cycle, type of the transmitter coil and body size. The especially in high and ultrahigh magnetic fields, important SAR issue can be readily addressed by reducing the RF duty cycle due to longer repetition times (TR) and the use of parallel imaging techniques. A TR longer than the minimum needed provides time for the tissue to cool down, but for the cost of a longer scan time. A parallel imaging technique reduces the RF exposure and the scan time.

See also High Field MRI.
spacer

• View the DATABASE results for 'Duty Cycle' (5).Open this link in a new window

MRI Resources 
Stent - Blood Flow Imaging - Lung Imaging - Coils - Mass Spectrometry - Colonography
 
previous      36 - 40 (of 84)     next
Result Pages : [1]  [2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17]
 Random Page
 
Share This Page
FacebookTwitterLinkedIn

MR-TIP    
Community   
User
Pass
Forgot your UserID/Password ?    



New acceleration techniques will :
reduce scan times 
cause artifacts 
increase expenses 
be useful if you have a lot of experience 
doesn't do much 
never heard of 

Look
      Ups





MR-TIP.com uses cookies! By browsing MR-TIP.com, you agree to our use of cookies.

Magnetic Resonance - Technology Information Portal
Member of SoftWays' Medical Imaging Group - MR-TIP • Radiology-TIP • Medical-Ultrasound-Imaging • 
Copyright © 2003 - 2024 SoftWays. All rights reserved. [ 21 November 2024]
Terms of Use | Privacy Policy | Advertising
 [last update: 2024-02-26 03:41:00]